Myopathological features in skeletal muscle of patients with chronic obstructive pulmonary disease

被引:117
|
作者
Gosker, HR
Kubat, B
Schaart, G
van der Vusse, GJ
Schols, AMWJ
机构
[1] Maastricht Univ, Dept Pulmonol, NL-6200 MD Maastricht, Netherlands
[2] Maastricht Univ, Dept Pathol, NL-6200 MD Maastricht, Netherlands
[3] Maastricht Univ, Dept Movement Sci, Nutr Toxicol & Environm Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
[4] Maastricht Univ, Dept Physiol, Cardiovasc Res Inst Maastricht, NL-6200 MD Maastricht, Netherlands
关键词
chronic obstructive pulmonary disease; histological techniques; skeletal muscle;
D O I
10.1183/09031936.03.00012803
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Despite the fact that muscle weakness is a major problem in chronic obstructive pulmonary disease (COPD), detailed information on myopathological changes at the microscopic level in these patients is scarce, if indeed available at all. Vastus lateralis biopsies of 15 COPD weight-stable patients (body mass index (BMI) 23.9+/-1.0 kg.m(-2); fat-free mass index (FFMI) 17.2+/-1.7 kg.m(-2)) and 16 healthy age-matched controls (BMI 26.3+/-0.8, kg.m(-2); FFMI 19.6+/-2.2 kg.m(-2)) were evaluated. Histochemistry was used to evaluate myopathological features. Immunohistochemistry was used for the detection of macrophages and leukocytes, and active caspase 3 and terminal deoxynucleotidyl transferase deoxyturidine triphosphate (dUTP) nick-end labelling (TUNEL) as markers of apoptosis. Fatty cell replacement and fibrosis were observed in both groups, the latter being slightly, but significantly, more pronounced in COPD. No differences between COPD, and controls were found with respect to central nuclei, necrosis, regeneration, or fibre splitting. Signs of mitochondrial abnormalities were absent and normal numbers of inflammatory cells were found. Active caspase 3 positive myocytes were not observed and no difference was found in the number of TUNEL-positive myonuclei between controls and COPD patients (1.1% versus 1.0%, respectively). The cross-sectional area of type-IIX muscle fibres was smaller in COPD than in controls (2,566 versus 4,248 mum(2)). Except for the I to IIX shift in fibre types, the selective type-IIX atrophy and a slight accompanying increase in fibrosis and fat cell replacement in chronic obstructive pulmonary disease relative to age-matched controls, no other morphological abnormalities were observed in the muscle biopsies of chronic obstructive pulmonary disease patients. Also, in this group of clinically and weight stable chronic obstructive pulmonary disease patients, apoptosis appeared not to be involved in muscle pathology.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 50 条
  • [21] Muscle Quality in Patients with Chronic Obstructive Pulmonary Disease
    Berry, Michael J.
    Adair, Norman E.
    Edgar, Kristen J.
    Kritchevsky, Stephen B.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2010, 42 (05): : 81 - 81
  • [22] Muscle catabolism in patients with chronic obstructive pulmonary disease
    Alvarez de Tejera, P. Montenegro
    Cabanes-Mariscal, M. A.
    Gutierrez-Ortega, C.
    Medina Font, J.
    Villa-Corbaton, M. C.
    Gomez de Terreros, J.
    REVISTA CLINICA ESPANOLA, 2011, 211 (10): : 511 - 516
  • [23] Prevalence of Mitochondrial Respiratory Chain Deficiency in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients
    Konokhova, Yana
    Picard, Martin
    Gouspillou, Gilles
    Kapchinsky, Sophia
    Baril, Jacinthe
    Jagoe, Thomas
    Taivassalo, Tanja
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2012, 44 : 691 - 691
  • [24] Ascorbate infusion increases skeletal muscle fatigue resistance in patients with chronic obstructive pulmonary disease
    Rossman, Matthew J.
    Garten, Ryan S.
    Groot, H. Jonathan
    Reese, Van
    Zhao, Jia
    Amann, Markus
    Richardson, Russell S.
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2013, 305 (10) : R1163 - R1170
  • [25] NUTRITIONAL STATE AND SKELETAL-MUSCLE METABOLISM IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY-DISEASE
    KUTSUZAWA, T
    KURITA, D
    HAIDA, M
    SHIOYA, S
    OHTA, Y
    YAMABAYASHI, H
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A200 - A200
  • [26] Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease
    Man, WDC
    Soliman, MGG
    Nikoletou, D
    Harris, ML
    Rafferty, GF
    Mustfa, N
    Polkey, MI
    Moxham, J
    THORAX, 2003, 58 (08) : 665 - 669
  • [27] Chronic obstructive pulmonary disease and resistance training: Improving skeletal muscle dysfunction
    Ronai, Peter
    Sorace, Paul
    STRENGTH AND CONDITIONING JOURNAL, 2007, 29 (06) : 58 - 60
  • [28] Telomere Shortening In Peripheral Skeletal Muscle Of Patient With Chronic Obstructive Pulmonary Disease
    Theriault, M-E.
    Pare, M-Eve.
    Maltais, F.
    Debigare, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [29] Emerging therapies for the treatment of skeletal muscle wasting in chronic obstructive pulmonary disease
    Passey, Samantha L.
    Hansen, Michelle J.
    Bozinovski, Steven
    McDonald, Christine F.
    Holland, Anne E.
    Vlahos, Ross
    PHARMACOLOGY & THERAPEUTICS, 2016, 166 : 56 - 70
  • [30] Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease
    Ju, Chun-Rong
    Chen, Rong-Chang
    RESPIRATORY MEDICINE, 2012, 106 (01) : 102 - 108